The target for disclosing abductive approach removes from prostate organs prostatic cell, collects the cell, and be then checked for cell colony. Such method includes that administration medicament promotes movement by target cell out of prostate, then moves to urethra. Typical activating agent includes 5α-reductase inhibitor. Cell is induced into urethra and then collects non-invasively, such as passes through urine or semen sample. Such preparation for gathering the opposite administration further strategically calculated, to maximize sample collection target cell of concern. The prostatic epithelium of slabbing is used subsequently to purpose, such as prostate cancer is detected, in prediction/measurement tumor of prostate susceptibility situation, automatic whose prostate biopsy of patient that monitors is the result is that negative, but continues to show symptom and meet prostate cancer, and the test with biomarker of identification false positive results.
